Please try another search
Acotec Scientific Holdings Limited operates as an interventional medical device company that offers vascular interventional treatment products in Mainland China, Europe, and internationally. The company’s products include AcoArt Orchid & Dhalia, a paclitaxel DCB used to prevent stenosis or occlusion in superficial femoral artery (SFA) and popliteal artery (PPA) for the treatment of lower extremity artery disease (LEAD) with a vascular interventional approach; and AcoArt Tulip & Litos, a paclitaxel coated DCB used to prevent stenosis or occlusion in below-theknee (BTK) arteries for the treatment of chronic limb-threatening ischemia with a vascular interventional approach. It also offers devices targeting vascular surgery, including AcoArt Iris & Jasmin; AcoArt Lily & Rosmarin; Peripheral Aspiration System (AcoStream); Radiofrequency Ablation System (AcoArt Cedar); Peripheral Support Catheter (Vericor); The PTA Balloon (P-Conic); and 2nd Gen Peripheral Aspiration System (2nd Generation AcoStream). In addition, its devices targeting cardiology include Semi-compliant PTCA Balloon (YAN), Coronary CTO Recanalization Balloon (RT-Zero), and Coronary CTO Antegrade Micro-Catheter (Vericor-14); devices targeting nephrology include Paclitaxel Coated High-Pressure Balloon (ACOART AVENS) and AV Scoring Balloon (Peridge); devices targeting neurology comprise Intracranial PTA Balloon (NEO-Skater); and devices targeting andrology include AcoArt Orchid & Dhalia and AcoArt Tulip & Litos. Further, the company trades procedural medical devices. The company was incorporated in 2020 and is headquartered in Beijing, China. Acotec Scientific Holdings Limited operates as a subsidiary of Boston Scientific Group plc.
Name | Age | Since | Title |
---|---|---|---|
Dierk Scheinert | - | - | Member of Scientific Advisory Board |
Sahil A. Parikh | - | 2021 | Member of Scientific Advisory Board |
Hong Ni | 52 | 2021 | Independent Non-Executive Director |
Arthur Crosswell Butcher | 53 | 2023 | Non-Executive Director |
Jing Li | 51 | 2017 | Executive Chairperson of the Board & CEO |
Kin Yee Poon | 51 | 2021 | Independent Non-Executive Director |
Yuqi Wang | 76 | 2021 | Independent Non-Executive Director |
Silvio Rudolf Schaffner | 52 | 2017 | COO & Executive Director |
Thomas Zeller | - | 2021 | Member of Scientific Advisory Board |
Matthew T. Menard | - | 2021 | Member of Scientific Advisory Board |
Peter A. Schneider | - | 2021 | Member of Scientific Advisory Board |
June Chang | 53 | 2023 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review